Skip to main content

Digital health integrations from
bench to bedside



Propeller gives you objective data on patient outcomes, plus the regulatory and engineering expertise you need to scale digital medicine globally.

For more than 10 years, Propeller has supported pharma and life sciences companies with unmatched data and technical expertise.

Male patient at home looking at his phone and holding an inhaler with Propeller sensor

For more than 10 years, Propeller has supported pharma and life sciences companies with unmatched data and technical expertise.

Visibility into patient behavior between refills

Propeller provides objective data to eliminate blind spots between refills, so you know if and when patients are taking their medication.

Objective data to support outcomes-based deals

Adherence data plus insights into rescue medication use help you strengthen your value to payers and providers alike.

Market share erosion management

With Propeller, differentiate your brand and defend against counterfeits with digital integrations that securely collect and transmit signals.


With Propeller, develop, deploy, and scale a digital therapeutic or digital companion globally.

With Propeller, develop, deploy, and scale a digital therapeutic or digital companion globally.

Deep clinical and real world experience

Propeller has conducted 80+ commercial programs and research studies, and a body of research no other digital health company can match: more than 150 peer-reviewed publications and abstracts.

Backed by ResMed’s global reach

Our parent company has decades of experience bringing specialized medical devices to market in more than 140 countries. Together, our regulatory expertise, logistics support, engineering and component sourcing knowledge is unmatched.

Unparallelled connectivity at scale

Our 10+ FDA and CE cleared devices cover more than 80% of all inhaled medications on the market – and our capabilities go far beyond respiratory care.


hands holding an inhaler with a sensor and a mother and her son sitting at the table


Propeller for Clinical Research

Propeller’s digital health platform enables decentralized clinical trials when included in the protocol for data collection and tracking purposes. Data captured during clinical trials can be used to support regulatory approval filings.

Propeller for Commercial 

Pharma and life sciences organizations can fully integrate or co-package a Propeller digital companion with their drug delivery devices (i.e., inhalers, injector pens, etc) for commercialized drugs or include Propeller as part of an integrated digital therapeutic model.

Featured Resources

Understanding Connected Drug Delivery: Inhalers, Injectors, and Infinite Possibilities

Between the rising global prevalence of chronic disease and a rapidly growing digital-first movement in healthcare, the development of connected drug delivery devices has increased significantly over the last several years. 

Even before the COVID-19 pandemic, the connected drug delivery devices market was experiencing steady growth. By the end of 2020, the market had grown 23.8% compared to the previous year.1 This expansion indicates that more than ever, embedding electronics and sensors into drug delivery devices including inhalers and injector pens is becoming more widely adopted. 

Navigating Outcomes-Based Deals: Better Disease Management Starts With Better Measurement

Healthcare is at an inflection point. In the United States, value-based models continue to grow, with value-based contracts expected to account for 22% of insured lives by 2025 – up 7% from current figures.1 At the same time, rising healthcare costs and changing government incentives are contributing to shifts in provider and payer demand.

So, what does all of this mean for pharmaceutical and life sciences companies? 

The Promise of Digital Health: Then, Now, and the Future

From the increased development of personalized therapeutics to the growing adoption of telemedicine, digital innovation has been applied to nearly every aspect of patient care and human health.

In a special publication with the National Academy of Medicine, Propeller Health and ResMed’s VP of Population Health Research, Meredith Barrett – alongside several luminaries in healthcare such as leaders from UCSF, Blue Shield of California, The Scripps Research Institute, and more – provides a comprehensive review of digital health solutions and identifies critical implementation opportunities including: 

Contact us to learn more about Propeller for your practice